{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T17:51:48Z","timestamp":1687888308874},"reference-count":31,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.3892\/ol.2011.255","type":"journal-article","created":{"date-parts":[[2011,1,23]],"date-time":"2011-01-23T13:52:00Z","timestamp":1295790720000},"page":"289-295","source":"Crossref","is-referenced-by-count":2,"title":["Therapy of Hodgkin\u2019s lymphoma in clinical practice: A retrospective long-term follow-up analysis"],"prefix":"10.3892","volume":"2","author":[{"given":"SARA","family":"AQUINO","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MARINO","family":"CLAVIO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"EDOARDO","family":"ROSSI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LUANA","family":"VIGNOLO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MAURIZIO","family":"MIGLINO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MAURO","family":"SPRIANO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LETIZIA","family":"CANEPA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"GIOACCHINO","family":"CATANIA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"IVANA","family":"PIERRI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MICAELA","family":"BERGAMASCHI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ROBERTA","family":"GONELLA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"CARLO","family":"MARANI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"OMAR","family":"RACCHI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MARINA","family":"CAVALIERE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"RICCARDO","family":"GORETTI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"FEDERICO","family":"CARBONE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ANDREA","family":"BRUZZONE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"RODOLFO","family":"TASSARA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ANGELO MICHELE","family":"CARELLA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"RICCARDO","family":"GHIO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MARCO","family":"GOBBI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2011,1,21]]},"reference":[{"key":"key20180108093502_b1-ol-02-02-0289","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1056\/NEJMe078173","article-title":"Hodgkin\u2019s disease, from pathology specimen to cure","volume":"357","author":"Diehl","year":"2007","journal-title":"N Engl J Med"},{"key":"key20180108093502_b2-ol-02-02-0289","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1056\/NEJM199811193392104","article-title":"A prognostic score for advanced Hodgkin\u2019s disease","volume":"339","author":"Hasenclever","year":"1998","journal-title":"N Engl J Med"},{"key":"key20180108093502_b3-ol-02-02-0289","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1056\/NEJM199211193272102","article-title":"Chemotherapy of advanced Hodgkin\u2019s disease with MOPP, ABVD, or MOPP alternating with ABVD","volume":"327","author":"Canellos","year":"1992","journal-title":"N Engl J Med"},{"key":"key20180108093502_b4-ol-02-02-0289","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1200\/JCO.2003.12.086","article-title":"Randomized comparison of ABVD and MOPP\/ABV hybrid for the treatment of advanced Hodgkin\u2019s disease: report of an intergroup trial","volume":"21","author":"Duggan","year":"2003","journal-title":"J Clin Oncol"},{"key":"key20180108093502_b5-ol-02-02-0289","doi-asserted-by":"crossref","first-page":"9198","DOI":"10.1200\/JCO.2005.02.907","article-title":"ABVD versus modified stanford V versus MOPPEBVCAD with optional and limited radiotherapy in intermediate- and advanced-stage Hodgkin\u2019s lymphoma: final results of a multicenter randomized trial by the Intergruppo Italiano Linfomi","volume":"23","author":"Gobbi","year":"2005","journal-title":"J Clin Oncol"},{"key":"key20180108093502_b6-ol-02-02-0289","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1056\/NEJMoa022473","article-title":"Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin\u2019s disease. Standard and increased-dose BEACOPP","volume":"348","author":"Diehl","year":"2003","journal-title":"N Eng J Med"},{"issue":"Suppl 9","key":"key20180108093502_b7-ol-02-02-0289","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/annonc\/mdm297","article-title":"Early, intermediate and advanced Hodgkin\u2019s lymphoma: modern treatment strategies","volume":"18","author":"Diehl","year":"2007","journal-title":"Ann Oncol"},{"key":"key20180108093502_b8-ol-02-02-0289","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1200\/JCO.2004.12.170","article-title":"ABVD plus subtotal nodal versus involved-field radiotherapy in early-stage Hodgkin\u2019s disease: long-term results","volume":"22","author":"Bonadonna","year":"2004","journal-title":"J Clin Oncol"},{"key":"key20180108093502_b9-ol-02-02-0289","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1200\/JCO.2005.02.9850","article-title":"Combined-modality therapy versus radiotherapy alone for treatment of early-stage Hodgkin\u2019s disease: cure balanced against complications","volume":"24","author":"Koontz","year":"2006","journal-title":"J Clin Oncol"},{"key":"key20180108093502_b10-ol-02-02-0289","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1200\/JCO.2006.07.0482","article-title":"Two cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine plus extended-field radiotherapy is superior to radiotherapy alone in early favorable Hodgkin\u2019s lymphoma: final results of the GHSG HD7 trial","volume":"25","author":"Engert","year":"2007","journal-title":"J Clin Oncol"},{"key":"key20180108093502_b11-ol-02-02-0289","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1056\/NEJMoa064601","article-title":"Chemotherapy plus involved-field radiation in early-stage Hodgkin\u2019s disease. EORTC-GELA H8 Trial","volume":"357","author":"Ferm\u00e8","year":"2007","journal-title":"N Engl J Med"},{"key":"key20180108093502_b12-ol-02-02-0289","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1056\/NEJMc073375","article-title":"Chemotherapy plus involved-field radiation in early-stage Hodgkin\u2019s disease","volume":"358","author":"Olweny","year":"2008","journal-title":"N Engl J Med"},{"key":"key20180108093502_b13-ol-02-02-0289","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1200\/JCO.2004.01.021","article-title":"Consolidation radiation after complete remission in Hodgkin\u2019s disease following six cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine chemotherapy: is there a need?","volume":"22","author":"Laskar","year":"2004","journal-title":"J Clin Oncol"},{"key":"key20180108093502_b14-ol-02-02-0289","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.1182\/blood-2004-04-1311","article-title":"Results of a prospective randomized clinical trial of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) followed by radiation therapy (RT) versus ABVD alone for stages I, II, and IIIA nonbulky Hodgkin disease","volume":"104","author":"Straus","year":"2004","journal-title":"Blood"},{"key":"key20180108093502_b15-ol-02-02-0289","doi-asserted-by":"crossref","first-page":"4634","DOI":"10.1200\/JCO.2005.09.085","article-title":"Randomized comparison of ABVD chemotherapy with a strategy that includes radiation therapy in patients with limited-stage Hodgkin\u2019s lymphoma: National Cancer Institute of Canada Clinical Trials Group and the Eastern Cooperative Oncology Group","volume":"23","author":"Meyer","year":"2005","journal-title":"J Clin Oncol"},{"key":"key20180108093502_b16-ol-02-02-0289","first-page":"255","article-title":"The management of patients with limited-stage classical Hodgkin lymphoma","volume-title":"ASH 2006 Educational Book","author":"Gospodarowicz","year":"2006"},{"key":"key20180108093502_b17-ol-02-02-0289","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1200\/JCO.2009.25.3260","article-title":"Treatment of favourable, limited-stage Hodgkin\u2019s lymphoma with chemotherapy without consolidation by radiation therapy","volume":"28","author":"Canellos","year":"2010","journal-title":"J Clin Oncol"},{"key":"key20180108093502_b18-ol-02-02-0289","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.3109\/10428194.2010.486090","article-title":"Long-term results of high-dose chemotherapy with autologous bone marrow or peripheral stem cell transplant as first salvage treatment for relapsed or refractory Hodgkin lymphoma: a single institution experience","volume":"51","author":"Viviani","year":"2010","journal-title":"Leuk Lymphoma"},{"key":"key20180108093502_b19-ol-02-02-0289","first-page":"816","article-title":"Ifosfamide, epirubicin and etoposide regimen as salvage and mobilizing therapy for relapsed\/refractory lymphoma patients","volume":"87","author":"Zinzani","year":"2002","journal-title":"Haematologica"},{"key":"key20180108093502_b20-ol-02-02-0289","first-page":"933","article-title":"Ifosfamide, epirubicin, etoposide (IEV) and autologous peripheral blood progenitor cell transplant: a feasible and effective salvage treatment for lymphoid malignancies","volume":"14","author":"Clavio","year":"2005","journal-title":"Oncol Rep"},{"key":"key20180108093502_b21-ol-02-02-0289","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3324\/haematol.10661","article-title":"Ifosfamide, gemcitabine, and vinorelbine: a new induction regimen for refractory and relapsed Hodgkin\u2019s lymphoma","volume":"92","author":"Santoro","year":"2007","journal-title":"Haematologica"},{"issue":"Suppl 1","key":"key20180108093502_b22-ol-02-02-0289","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/annonc\/8.suppl_1.S115","article-title":"Hodgkin\u2019s disease: complications of therapy and excess mortality","volume":"8","author":"Hoppe","year":"1997","journal-title":"Ann Oncol"},{"key":"key20180108093502_b23-ol-02-02-0289","article-title":"World Health Organization Classification of Tumors","volume-title":"Pathology and Genetics of Tumors of Haematopoietic and Lymphoid Tissues","author":"Jaffe","year":"2001"},{"key":"key20180108093502_b24-ol-02-02-0289","doi-asserted-by":"crossref","first-page":"550","DOI":"10.3324\/haematol.2008.002451","article-title":"Classical Hodgkin\u2019s lymphoma in adults: guidelines of the Italian Society of Hematology, the Italian Society of Experimental Hematology, and the Italian Group for Bone Marrow Transplantation on initial work-up, management, and follow-up","volume":"94","author":"Brusamolino","year":"2009","journal-title":"Haematologica"},{"key":"key20180108093502_b25-ol-02-02-0289","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.3109\/10428194.2010.500432","article-title":"Late relapses in Hodgkin Lymphoma: a clinical and immunochemistry study","volume":"51","author":"Provencio","year":"2010","journal-title":"Leuk Lymphoma"},{"key":"key20180108093502_b26-ol-02-02-0289","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1002\/1097-0142(19900401)65:7<1635::AID-CNCR2820650730>3.0.CO;2-M","article-title":"Survival of the older patient compared with the younger patient with Hodgkin\u2019s disease. Influence of histologic type, staging, and treatment","volume":"65","author":"Walker","year":"1990","journal-title":"Cancer"},{"key":"key20180108093502_b27-ol-02-02-0289","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/hon.2900130104","article-title":"Outcome of Hodgkin\u2019s disease in elderly patients","volume":"13","author":"Diaz-Pavon","year":"1995","journal-title":"Hematol Oncol"},{"key":"key20180108093502_b28-ol-02-02-0289","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.3324\/haematol.2010.024885","article-title":"Positron emission tomography scanning: a new paradigm for the management of Hodgkin\u2019s lymphoma","volume":"95","author":"Gallamini","year":"2010","journal-title":"Haematologica"},{"key":"key20180108093502_b29-ol-02-02-0289","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s00277-009-0699-5","article-title":"The addition of radiotherapy to chemotherapy does not improve outcome of early stage Hodgkin\u2019s lymphoma patients: a retrospective long-term follow-up analysis of a regional Italian experience","volume":"88","author":"Olcese","year":"2009","journal-title":"Ann Hematol"},{"key":"key20180108093502_b30-ol-02-02-0289","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.radonc.2007.10.016","article-title":"Heart and coronary artery protection in patients with mediastinal Hodgkin lymphoma treated with intensity-modulated radiotherapy: dose constraints to virtual volumes or to organs at risk?","volume":"87","author":"Ghalibafian","year":"2008","journal-title":"Radiother Oncol"},{"key":"key20180108093502_b31-ol-02-02-0289","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1182\/asheducation-2007.1.192","article-title":"Evaluation of the risk of therapy-associated complications in survivors of Hodgkin lymphoma","author":"Travis","year":"2007","journal-title":"Hematology Am Soc Hematol Educ Program"}],"container-title":["Oncology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ol.2011.255\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,15]],"date-time":"2020-06-15T23:17:14Z","timestamp":1592263034000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ol.2011.255"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1,21]]},"references-count":31,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2011,1,21]]},"published-print":{"date-parts":[[2011,3]]}},"alternative-id":["10.3892\/ol.2011.255"],"URL":"https:\/\/doi.org\/10.3892\/ol.2011.255","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1,21]]}}}